Vertex Pharmaceuticals On Track for Largest Percent Increase Since January — Data Talk Vertex Pharmaceuticals Incorporated (VRTX) is currently at $405.74, up $14.10 or 3.6% --Would be highest close ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Artificial intelligence startup Vercel raised $300 million in a new funding round led by Accel and Singapore’s sovereign ...
Axiom Math, which has recruited top talent from Meta, has raised $64 million in seed funding to build an AI math whiz.
Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...
Zacks Investment Research on MSN
Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
Vertex Pharmaceuticals (VRTX) ended the recent trading session at $381.87, demonstrating a +1.39% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.5%. At ...
Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...
Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback